VIR-7831 constitute a novel class of protein interventions designed to inhibit the coronavirus pathogen . Initially , sotrovimab, created by the companies, demonstrated significant effectiveness against https://neilqhop843890.blog-gold.com/59670405/sotrovimab-vir-7831-a-deep-investigation-into-the-antibody-intervention